Comparative efficacy of forphenicinol, cyclosporine, and amphotericin B in experimental murine coccidioidomycosis

Cohorts of ten mice, uninfected and infected (intratracheal injection of coccidioidal arthroconidia), were treated for 23 days by intravenous injections of either 5% glucose solution, an immunostimulant (forphenicinol), an immunodepressant (cyclosporine), or amphotericin B. All mice were autopsied (...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Diagnostic microbiology and infectious disease 1987-04, Vol.6 (4), p.287-292
Hauptverfasser: Hoeprich, Paul D., Merry, Joanne M.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 292
container_issue 4
container_start_page 287
container_title Diagnostic microbiology and infectious disease
container_volume 6
creator Hoeprich, Paul D.
Merry, Joanne M.
description Cohorts of ten mice, uninfected and infected (intratracheal injection of coccidioidal arthroconidia), were treated for 23 days by intravenous injections of either 5% glucose solution, an immunostimulant (forphenicinol), an immunodepressant (cyclosporine), or amphotericin B. All mice were autopsied (survivors at 26 days postinoculation) and suspensions of lungs, livers, and spleens were cultured. All uninfected animals survived and gained weight, whereas, only 20% of the infected controls survived, and all lost weight. Treatment with forphenicinol had no effect on survival or weight. Cyclosporine secured 90% survival at the lowest dose and 60% at the higher doses, with no net loss of weight; however, all cultures of organs yielded heavy growth of Coccidioides immitis . With amphotericin B, all mice survived and gained weight; four mice from each of the two treatment groups yielded modest growth of C . immitis from the lungs, and one mouse of each group yielded sparse growth from liver and spleen. The paradox of no effect from an immunostimulant and therapeutic effect from an immunodepressant correlated with susceptibility testing of C . immitis in vitro.
doi_str_mv 10.1016/0732-8893(87)90177-5
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_77526571</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>0732889387901775</els_id><sourcerecordid>77526571</sourcerecordid><originalsourceid>FETCH-LOGICAL-c386t-438c2a22775d70a48a2bceda157b8cce6eaa0032ced3a7a7d162c3fda3dfbf813</originalsourceid><addsrcrecordid>eNp9kE2LFDEQhoMo6-zqP1DIQURhW_Mx3clcFnTwCxa86DnUVCpspLvTm_Qszr83vTPM0UtCUk-9VD2MvZLigxSy-yiMVo21G_3OmvcbIY1p2idsJa3ZNEIY8ZStzshzdlnKHyGk2qzFBbvQrZVGtyt2v03DBBnm-ECcQogIeOAp8JDydEdjxDim_prjAftUppTjSNccRs9hmO7STHkh-GdeD_o71edA4ww9H_YLyjEhRh9T9Gk4YCqxvGDPAvSFXp7uK_b765df2-_N7c9vP7afbhvUtpubtbaoQCljWm8ErC2oHZIH2ZqdRaSOAITQqv5pMGC87BTq4EH7sAtW6iv29pg75XS_pzK7IRakvoeR0r64Gqy61izg-ghiTqVkCm6qW0A-OCncYtotGt2i0VnjHk27tra9PuXvdwP5c9NJba2_OdWhIPQhw4ixnDHTKWm1qdjNEaPq4iFSdgUjjXWtmAln51P8_xz_ALyVnXQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>77526571</pqid></control><display><type>article</type><title>Comparative efficacy of forphenicinol, cyclosporine, and amphotericin B in experimental murine coccidioidomycosis</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Hoeprich, Paul D. ; Merry, Joanne M.</creator><creatorcontrib>Hoeprich, Paul D. ; Merry, Joanne M.</creatorcontrib><description>Cohorts of ten mice, uninfected and infected (intratracheal injection of coccidioidal arthroconidia), were treated for 23 days by intravenous injections of either 5% glucose solution, an immunostimulant (forphenicinol), an immunodepressant (cyclosporine), or amphotericin B. All mice were autopsied (survivors at 26 days postinoculation) and suspensions of lungs, livers, and spleens were cultured. All uninfected animals survived and gained weight, whereas, only 20% of the infected controls survived, and all lost weight. Treatment with forphenicinol had no effect on survival or weight. Cyclosporine secured 90% survival at the lowest dose and 60% at the higher doses, with no net loss of weight; however, all cultures of organs yielded heavy growth of Coccidioides immitis . With amphotericin B, all mice survived and gained weight; four mice from each of the two treatment groups yielded modest growth of C . immitis from the lungs, and one mouse of each group yielded sparse growth from liver and spleen. The paradox of no effect from an immunostimulant and therapeutic effect from an immunodepressant correlated with susceptibility testing of C . immitis in vitro.</description><identifier>ISSN: 0732-8893</identifier><identifier>EISSN: 1879-0070</identifier><identifier>DOI: 10.1016/0732-8893(87)90177-5</identifier><identifier>PMID: 3581735</identifier><identifier>CODEN: DMIDDZ</identifier><language>eng</language><publisher>New York, NY: Elsevier Inc</publisher><subject>Amphotericin B - pharmacology ; Amphotericin B - therapeutic use ; Animals ; Anti-Bacterial Agents - pharmacology ; Anti-Bacterial Agents - therapeutic use ; Antibiotics. Antiinfectious agents. Antiparasitic agents ; Antifungal agents ; Biological and medical sciences ; Body Weight ; Coccidioides - drug effects ; Coccidioides - isolation &amp; purification ; Coccidioidomycosis - drug therapy ; Cyclosporins - pharmacology ; Cyclosporins - therapeutic use ; Female ; Glycine - analogs &amp; derivatives ; Glycine - pharmacology ; Glycine - therapeutic use ; Liver - microbiology ; Lung - microbiology ; Medical sciences ; Mice ; Pharmacology. Drug treatments ; Spleen - microbiology</subject><ispartof>Diagnostic microbiology and infectious disease, 1987-04, Vol.6 (4), p.287-292</ispartof><rights>1987</rights><rights>1988 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c386t-438c2a22775d70a48a2bceda157b8cce6eaa0032ced3a7a7d162c3fda3dfbf813</citedby><cites>FETCH-LOGICAL-c386t-438c2a22775d70a48a2bceda157b8cce6eaa0032ced3a7a7d162c3fda3dfbf813</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/0732-8893(87)90177-5$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,777,781,3537,27905,27906,45976</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=7621837$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/3581735$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Hoeprich, Paul D.</creatorcontrib><creatorcontrib>Merry, Joanne M.</creatorcontrib><title>Comparative efficacy of forphenicinol, cyclosporine, and amphotericin B in experimental murine coccidioidomycosis</title><title>Diagnostic microbiology and infectious disease</title><addtitle>Diagn Microbiol Infect Dis</addtitle><description>Cohorts of ten mice, uninfected and infected (intratracheal injection of coccidioidal arthroconidia), were treated for 23 days by intravenous injections of either 5% glucose solution, an immunostimulant (forphenicinol), an immunodepressant (cyclosporine), or amphotericin B. All mice were autopsied (survivors at 26 days postinoculation) and suspensions of lungs, livers, and spleens were cultured. All uninfected animals survived and gained weight, whereas, only 20% of the infected controls survived, and all lost weight. Treatment with forphenicinol had no effect on survival or weight. Cyclosporine secured 90% survival at the lowest dose and 60% at the higher doses, with no net loss of weight; however, all cultures of organs yielded heavy growth of Coccidioides immitis . With amphotericin B, all mice survived and gained weight; four mice from each of the two treatment groups yielded modest growth of C . immitis from the lungs, and one mouse of each group yielded sparse growth from liver and spleen. The paradox of no effect from an immunostimulant and therapeutic effect from an immunodepressant correlated with susceptibility testing of C . immitis in vitro.</description><subject>Amphotericin B - pharmacology</subject><subject>Amphotericin B - therapeutic use</subject><subject>Animals</subject><subject>Anti-Bacterial Agents - pharmacology</subject><subject>Anti-Bacterial Agents - therapeutic use</subject><subject>Antibiotics. Antiinfectious agents. Antiparasitic agents</subject><subject>Antifungal agents</subject><subject>Biological and medical sciences</subject><subject>Body Weight</subject><subject>Coccidioides - drug effects</subject><subject>Coccidioides - isolation &amp; purification</subject><subject>Coccidioidomycosis - drug therapy</subject><subject>Cyclosporins - pharmacology</subject><subject>Cyclosporins - therapeutic use</subject><subject>Female</subject><subject>Glycine - analogs &amp; derivatives</subject><subject>Glycine - pharmacology</subject><subject>Glycine - therapeutic use</subject><subject>Liver - microbiology</subject><subject>Lung - microbiology</subject><subject>Medical sciences</subject><subject>Mice</subject><subject>Pharmacology. Drug treatments</subject><subject>Spleen - microbiology</subject><issn>0732-8893</issn><issn>1879-0070</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1987</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kE2LFDEQhoMo6-zqP1DIQURhW_Mx3clcFnTwCxa86DnUVCpspLvTm_Qszr83vTPM0UtCUk-9VD2MvZLigxSy-yiMVo21G_3OmvcbIY1p2idsJa3ZNEIY8ZStzshzdlnKHyGk2qzFBbvQrZVGtyt2v03DBBnm-ECcQogIeOAp8JDydEdjxDim_prjAftUppTjSNccRs9hmO7STHkh-GdeD_o71edA4ww9H_YLyjEhRh9T9Gk4YCqxvGDPAvSFXp7uK_b765df2-_N7c9vP7afbhvUtpubtbaoQCljWm8ErC2oHZIH2ZqdRaSOAITQqv5pMGC87BTq4EH7sAtW6iv29pg75XS_pzK7IRakvoeR0r64Gqy61izg-ghiTqVkCm6qW0A-OCncYtotGt2i0VnjHk27tra9PuXvdwP5c9NJba2_OdWhIPQhw4ixnDHTKWm1qdjNEaPq4iFSdgUjjXWtmAln51P8_xz_ALyVnXQ</recordid><startdate>19870401</startdate><enddate>19870401</enddate><creator>Hoeprich, Paul D.</creator><creator>Merry, Joanne M.</creator><general>Elsevier Inc</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19870401</creationdate><title>Comparative efficacy of forphenicinol, cyclosporine, and amphotericin B in experimental murine coccidioidomycosis</title><author>Hoeprich, Paul D. ; Merry, Joanne M.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c386t-438c2a22775d70a48a2bceda157b8cce6eaa0032ced3a7a7d162c3fda3dfbf813</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1987</creationdate><topic>Amphotericin B - pharmacology</topic><topic>Amphotericin B - therapeutic use</topic><topic>Animals</topic><topic>Anti-Bacterial Agents - pharmacology</topic><topic>Anti-Bacterial Agents - therapeutic use</topic><topic>Antibiotics. Antiinfectious agents. Antiparasitic agents</topic><topic>Antifungal agents</topic><topic>Biological and medical sciences</topic><topic>Body Weight</topic><topic>Coccidioides - drug effects</topic><topic>Coccidioides - isolation &amp; purification</topic><topic>Coccidioidomycosis - drug therapy</topic><topic>Cyclosporins - pharmacology</topic><topic>Cyclosporins - therapeutic use</topic><topic>Female</topic><topic>Glycine - analogs &amp; derivatives</topic><topic>Glycine - pharmacology</topic><topic>Glycine - therapeutic use</topic><topic>Liver - microbiology</topic><topic>Lung - microbiology</topic><topic>Medical sciences</topic><topic>Mice</topic><topic>Pharmacology. Drug treatments</topic><topic>Spleen - microbiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hoeprich, Paul D.</creatorcontrib><creatorcontrib>Merry, Joanne M.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Diagnostic microbiology and infectious disease</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hoeprich, Paul D.</au><au>Merry, Joanne M.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Comparative efficacy of forphenicinol, cyclosporine, and amphotericin B in experimental murine coccidioidomycosis</atitle><jtitle>Diagnostic microbiology and infectious disease</jtitle><addtitle>Diagn Microbiol Infect Dis</addtitle><date>1987-04-01</date><risdate>1987</risdate><volume>6</volume><issue>4</issue><spage>287</spage><epage>292</epage><pages>287-292</pages><issn>0732-8893</issn><eissn>1879-0070</eissn><coden>DMIDDZ</coden><abstract>Cohorts of ten mice, uninfected and infected (intratracheal injection of coccidioidal arthroconidia), were treated for 23 days by intravenous injections of either 5% glucose solution, an immunostimulant (forphenicinol), an immunodepressant (cyclosporine), or amphotericin B. All mice were autopsied (survivors at 26 days postinoculation) and suspensions of lungs, livers, and spleens were cultured. All uninfected animals survived and gained weight, whereas, only 20% of the infected controls survived, and all lost weight. Treatment with forphenicinol had no effect on survival or weight. Cyclosporine secured 90% survival at the lowest dose and 60% at the higher doses, with no net loss of weight; however, all cultures of organs yielded heavy growth of Coccidioides immitis . With amphotericin B, all mice survived and gained weight; four mice from each of the two treatment groups yielded modest growth of C . immitis from the lungs, and one mouse of each group yielded sparse growth from liver and spleen. The paradox of no effect from an immunostimulant and therapeutic effect from an immunodepressant correlated with susceptibility testing of C . immitis in vitro.</abstract><cop>New York, NY</cop><pub>Elsevier Inc</pub><pmid>3581735</pmid><doi>10.1016/0732-8893(87)90177-5</doi><tpages>6</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0732-8893
ispartof Diagnostic microbiology and infectious disease, 1987-04, Vol.6 (4), p.287-292
issn 0732-8893
1879-0070
language eng
recordid cdi_proquest_miscellaneous_77526571
source MEDLINE; Elsevier ScienceDirect Journals
subjects Amphotericin B - pharmacology
Amphotericin B - therapeutic use
Animals
Anti-Bacterial Agents - pharmacology
Anti-Bacterial Agents - therapeutic use
Antibiotics. Antiinfectious agents. Antiparasitic agents
Antifungal agents
Biological and medical sciences
Body Weight
Coccidioides - drug effects
Coccidioides - isolation & purification
Coccidioidomycosis - drug therapy
Cyclosporins - pharmacology
Cyclosporins - therapeutic use
Female
Glycine - analogs & derivatives
Glycine - pharmacology
Glycine - therapeutic use
Liver - microbiology
Lung - microbiology
Medical sciences
Mice
Pharmacology. Drug treatments
Spleen - microbiology
title Comparative efficacy of forphenicinol, cyclosporine, and amphotericin B in experimental murine coccidioidomycosis
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-20T16%3A05%3A08IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Comparative%20efficacy%20of%20forphenicinol,%20cyclosporine,%20and%20amphotericin%20B%20in%20experimental%20murine%20coccidioidomycosis&rft.jtitle=Diagnostic%20microbiology%20and%20infectious%20disease&rft.au=Hoeprich,%20Paul%20D.&rft.date=1987-04-01&rft.volume=6&rft.issue=4&rft.spage=287&rft.epage=292&rft.pages=287-292&rft.issn=0732-8893&rft.eissn=1879-0070&rft.coden=DMIDDZ&rft_id=info:doi/10.1016/0732-8893(87)90177-5&rft_dat=%3Cproquest_cross%3E77526571%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=77526571&rft_id=info:pmid/3581735&rft_els_id=0732889387901775&rfr_iscdi=true